Zhifeng Han

Plasma anti‐<scp>BIRC</scp>5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer

Huan Zhao, Xuan Zhang, Zhifeng Han et al. · FEBS Open Bio · 2018 · 113 citations · Full text

Medicine, Immunology, Oncology +16

Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis

Liping Ma, Hongjun Peng, Kunsheng Li et al. · Molecular Medicine Reports · 2015 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16

Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population

Jianfei Yao, Yuan Gong, Wei Zhao et al. · Scientific Reports · 2019 · 54 citations · Full text

Life Sciences, Genetics, Oncology +17

Transformer for Gene Expression Modeling (T-GEM): An Interpretable Deep Learning Model for Gene Expression-Based Phenotype Predictions

Tinghe Zhang, Md Musaddaqul Hasib, Yu‐Chiao Chiu et al. · Cancers · 2022 · 49 citations · Full text

Life Sciences, Cancer Biology, Oncology +13

RNA sequencing uncovers the key long non‑coding RNAs and potential molecular mechanism contributing to XAV939‑mediated inhibition of non‑small cell lung cancer

Haixiang Yu, Zhifeng Han, Zhenan Xu et al. · Oncology Letters · 2019 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +17